Annual Cash & Cash Equivalents
$63.71 M
-$79.80 M-55.61%
December 31, 2022
Summary
- As of February 10, 2025, SQZ annual cash & cash equivalents is $63.71 million, with the most recent change of -$79.80 million (-55.61%) on December 31, 2022.
- During the last 3 years, SQZ annual cash & cash equivalents has risen by +$24.45 million (+62.30%).
Performance
SQZ Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$39.87 M
-$23.84 M-37.42%
March 31, 2023
Summary
- As of February 10, 2025, SQZ quarterly cash and cash equivalents is $39.87 million, with the most recent change of -$23.84 million (-37.42%) on March 31, 2023.
- Over the past year, SQZ quarterly cash and cash equivalents has dropped by -$83.04 million (-67.56%).
Performance
SQZ Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SQZ Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.6% | -67.6% |
| 3 y3 years | +62.3% | - |
| 5 y5 years | +7.0% | - |
SQZ Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | at low | -72.2% | at low |
| 5 y | 5-year | -62.6% | -38.4% | -80.5% | -1.5% |
| alltime | all time | -62.6% | -38.4% | -80.5% | -1.5% |
SQZ Biotechnologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $39.87 M(-37.4%) |
| Dec 2022 | $63.71 M(-55.6%) | $63.71 M(-24.4%) |
| Sep 2022 | - | $84.24 M(-20.2%) |
| Jun 2022 | - | $105.56 M(-14.1%) |
| Mar 2022 | - | $122.91 M(-14.4%) |
| Dec 2021 | $143.51 M | $143.51 M(-12.6%) |
| Sep 2021 | - | $164.25 M(-11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $185.07 M(-9.7%) |
| Mar 2021 | - | $204.93 M(+20.3%) |
| Dec 2020 | $170.36 M(+334.0%) | $170.36 M(+59.1%) |
| Sep 2020 | - | $107.06 M(-6.6%) |
| Jun 2020 | - | $114.65 M(+192.1%) |
| Dec 2019 | $39.26 M(-34.1%) | $39.26 M |
| Dec 2018 | $59.57 M | - |
FAQ
- What is SQZ Biotechnologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for SQZ Biotechnologies?
- What is SQZ Biotechnologies annual cash & cash equivalents year-on-year change?
- What is SQZ Biotechnologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for SQZ Biotechnologies?
- What is SQZ Biotechnologies quarterly cash and cash equivalents year-on-year change?
What is SQZ Biotechnologies annual cash & cash equivalents?
The current annual cash & cash equivalents of SQZ is $63.71 M
What is the all time high annual cash & cash equivalents for SQZ Biotechnologies?
SQZ Biotechnologies all-time high annual cash & cash equivalents is $170.36 M
What is SQZ Biotechnologies annual cash & cash equivalents year-on-year change?
Over the past year, SQZ annual cash & cash equivalents has changed by -$79.80 M (-55.61%)
What is SQZ Biotechnologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SQZ is $39.87 M
What is the all time high quarterly cash and cash equivalents for SQZ Biotechnologies?
SQZ Biotechnologies all-time high quarterly cash and cash equivalents is $204.93 M
What is SQZ Biotechnologies quarterly cash and cash equivalents year-on-year change?
Over the past year, SQZ quarterly cash and cash equivalents has changed by -$83.04 M (-67.56%)